Home
Market
IPO
Screener
Bundles
Super Investors
Sector
Discover
TickerPlus
Account
Shiva Pharmachem
Consolidated
Standalone
Peers
P&L
Balance Sheet
Cash Flows
Corp. Action
News
Ticker
>
Company
>
Shiva Pharmachem share price
Shiva Pharmachem Ltd.
550
0
0
The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.
Peer Comparison
View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.
Ratios
Sales Growth
1 Year
7.49%
3 Year
5.98%
5 Year
9%
Profit Growth
1 Year
19.28%
3 Year
-11.54%
5 Year
79.92%
ROE%
1 Year
21.86%
3 Year
23.45%
5 Year
34.41%
ROCE %
1 Year
21.89%
3 Year
21.86%
5 Year
25.52%
Debt/Equity
0.4603
Price to Cash Flow
0
Interest Cover Ratio
0
CFO/PAT
(5 Yr. Avg.)
0
Strengths
Company has been maintaining healthy ROE of
23.4481572216131
% over the past 3 years.
Company has been maintaining healthy ROCE of
21.8634004660259
% over the past 3 years.
The company has an efficient Cash Conversion Cycle of
0
days.
Limitations
The company has shown a poor profit growth of
-11.5423823812367
% for the Past 3 years.
The company has shown a poor revenue growth of
5.98495515937909
% for the Past 3 years.
Company has low Interest coverage ratio of
0
.
The company has a low EBITDA margin of
0
% over the past 5 years.
Profit & Loss
(All Figures in Cr. Adjusted EPS in Rs.)
PARTICULARS
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Net Sales
705.87
639.81
527.74
708.61
761.7
Total Expenditure
590.29
476.67
421.05
576.65
606.22
Operating Profit
115.58
163.14
106.69
131.96
155.48
Other Income
8.78
37.86
15.37
12.68
12.98
Interest
20.78
14.11
7.45
6.67
9.73
Depreciation
32.88
28
22.6
37.32
35.48
Exceptional Items
0
-0.87
0
0
0
Profit Before Tax
70.7
158.01
92.01
100.65
123.25
Tax
8.94
29.26
24.27
25.94
34.13
Net Profit
61.76
128.75
67.74
74.71
89.12
Adjusted EPS (Rs.)
5.92
12.35
6.38
7.04
8.39
Balance Sheet
(All Figures are in Crores.)
Particulars
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Equity and Liabilities
Share Capital
6.95
6.95
7.08
7.08
21.24
Total Reserves
175.33
233.78
281.91
356.29
430.9
Borrowings
66.23
56.47
50.34
34.49
9.38
Other N/C liabilities
-2.66
-3.92
14.83
16.21
7.11
Current liabilities
277.42
248.62
191.34
284.43
320.64
Total Liabilities
523.27
541.89
545.5
698.5
789.28
Assets
Net Block
151.23
112.5
173.08
178.34
179.54
Capital WIP
19.11
53.47
35.5
40.28
84.01
Intangible WIP
0
0
0
0
0
Investments
20.28
28.75
40.09
40.99
57.42
Loans & Advances
21.07
34.45
2.56
8.32
2.84
Other N/C Assets
0
0
5.18
0
0.18
Current Assets
311.58
312.72
289.09
430.58
465.29
Total Assets
523.27
541.89
545.5
698.5
789.28
* Other Non-current Liabilities include Net deferred Liabilities
Cash Flows
(All Figures are in Crores.)
PARTICULARS
Mar 2022
Mar 2023
Profit from operations
100.65
123.25
Adjustment
41.58
40.01
Changes in Assets & Liabilities
-142.33
-75.88
Tax Paid
0
0
Operating Cash Flow
-0.1
87.38
Investing Cash Flow
-47.3
-92.91
Financing Cash Flow
36.45
7.94
Net Cash Flow
-10.95
2.4
Corporate Actions
Dividend
Bonus
Rights
Split
Company News
No Latest News available for this company.
Report us
Last Updated on:
Brief about Shiva Pharmachem
x
Ratio Delete Confirmation
×
Are you sure you want to DELETE
from your ratio list? This will also hide it from all other companies that you analyze.
X